Author

Stacey Richardson

Observed name: S Richardson

Observed institution: Newcastle University

ORCID: 0000-0003-1841-6330

Observed ORCID: 0000-0003-1841-6330

OpenAlex ID: A5069436685

A novel integrated cytogenetic and genomic classification refines risk stratification in pediatric acute lymphoblastic leukemia

2014 · Anthony V. Moorman, Amir Enshaei, et al. · Blood · 215

EBF1-PDGFRB fusion in pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL): genetic profile and clinical implications

2016 · Claire Schwab, Sarra L. Ryan, et al. · Blood · 129

PDF

Time, pattern, and outcome of medulloblastoma relapse and their association with tumour biology at diagnosis and therapy: a multicentre cohort study

2020 · Rebecca M Hill, Stacey Richardson, et al. · The Lancet Child & Adolescent Health · 102

PDF

Medulloblastoma group 3 and 4 tumors comprise a clinically and biologically significant expression continuum reflecting human cerebellar development

2022 · Daniel Williamson, Edward C. Schwalbe, et al. · Cell Reports · 87

PDF

Emergence and maintenance of actionable genetic drivers at medulloblastoma relapse

2021 · Stacey Richardson, Rebecca M Hill, et al. · Neuro-Oncology · 50

PDF

The role of the RAS pathway in iAMP21-ALL

2016 · S L Ryan, E Matheson, et al. · Leukemia · 44

PDF

Disease-associated KBTBD4 mutations in medulloblastoma elicit neomorphic ubiquitylation activity to promote CoREST degradation

2022 · Zhuoyao Chen, Rafael M. Ioris, et al. · Cell Death and Differentiation · 40

PDF

Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma

2022 · Anna Borgenvik, Karl O. Holmberg, et al. · Cancer Research · 26

PDF

Molecular characterisation defines clinically-actionable heterogeneity within Group 4 medulloblastoma and improves disease risk-stratification

2023 · Jack Goddard, Jemma Castle, et al. · Acta Neuropathologica · 23

PDF

ARF suppression by MYC but not MYCN confers increased malignancy of aggressive pediatric brain tumors

2023 · Oliver J. Mainwaring, Holger Weishaupt, et al. · Nature Communications · 19

PDF

SSBP2-CSF1R Is a Recurrent Fusion in B-Other Acute Lymphoblastic Leukaemia with Variable Clinical Outcome

2014 · Claire Schwab, Rebecca Andrews, et al. · Blood · 6

Medu-16. Time, Pattern and Outcome of Medulloblastoma Relapse Is Biology and Therapy-dependent

2017 · Rebecca Hill, Stacey Richardson, et al. · Neuro-Oncology · 3

Integrated biomarker and treatment correlates of prognosis in infant non-WNT/non-SHH medulloblastoma: a multinational retrospective cohort study

2026 · Stacey Richardson, Debbie Hicks, et al. · The Lancet Child & Adolescent Health · 2

MIF-CD74 signaling drives immune modulation in medulloblastoma

2026 · Benjamin Draper, Zhen You, et al. · Neuro-Oncology · 2

EBF1-PDGFRΒ Fusion in Paediatric Acute Lymphoblastic Leukaemia (ALL): Genetic Profile and Clinical Implications

2014 · Claire Schwab, Rebecca Andrews, et al. · Blood · 2

MEDB-62. Disease-associated KBTBD4 mutations in medulloblastoma elicit neomorphic ubiquitylation activity to promote CoREST degradation

2022 · Zhuoyao Chen, Rafael Ioris, et al. · Neuro-Oncology · 1

ID #468 Identifying targetable driver genes to circumvent medulloblastoma relapse

2026 · Melanie Beckett, Joe Edwards, et al. · Neuro-Oncology Pediatrics

Therapy and biomarker dependent progression-free survival in infant sonic hedgehog medulloblastoma: a multi-national retrospective cohort study

2026 · Stacey Richardson, Debbie Hicks, et al. · EClinicalMedicine

Supplementary Data from Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma